Kaylene Little - Tassal Group Head of Human Resources, QA and OH&S
Executive
Ms. Kaylene Little is the Head of People, Culture and QA of the company. since 2014.
| Tenure | 11 years |
| Phone | 61 3 6244 9099 |
| Web | https://www.tassalgroup.com.au |
Tassal Group Management Efficiency
The company has return on total asset (ROA) of 0.0452 % which means that it generated a profit of $0.0452 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0674 %, meaning that it generated $0.0674 on every $100 dollars invested by stockholders. Tassal Group's management efficiency ratios could be used to measure how well Tassal Group manages its routine affairs as well as how well it operates its assets and liabilities.Tassal Group Limited has accumulated 357.08 M in total debt with debt to equity ratio (D/E) of 0.67, which is about average as compared to similar companies. Tassal Group Limited has a current ratio of 3.69, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Tassal Group until it has trouble settling it off, either with new capital or with free cash flow. So, Tassal Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Tassal Group Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Tassal to invest in growth at high rates of return. When we think about Tassal Group's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Justin LaFountaine | Spyre Therapeutics | N/A | |
| Andrew Spencer | Spyre Therapeutics | N/A | |
| Stefanie JD | Genfit | 43 | |
| Robert Felsch | Ardelyx | N/A | |
| MPH MD | Ardelyx | 61 | |
| Ashraf Amanullah | Inhibrx | 57 | |
| Brian Connolly | Spyre Therapeutics | N/A | |
| Janet MBA | Spyre Therapeutics | N/A | |
| CFE CPA | Spyre Therapeutics | N/A | |
| Elizabeth Esq | Ardelyx | 61 | |
| Carlos Bais | Inhibrx | N/A | |
| Jeffrey Jensen | Inhibrx | N/A | |
| Joshua MD | Spyre Therapeutics | N/A | |
| Charon Sr | Ardelyx | N/A | |
| Eric McIntyre | Spyre Therapeutics | N/A | |
| Emilie Desodt | Genfit | 41 | |
| Christopher DeSantis | Waste Management | 60 | |
| David MBA | Inhibrx | N/A | |
| Laurent Lannoo | Genfit | 54 | |
| Johnson Varkey | Waste Management | 53 | |
| Deanna MD | Spyre Therapeutics | N/A | |
Management Performance
| Return On Equity | 0.0674 | |||
| Return On Asset | 0.0452 |
Tassal Group Limited Leadership Team
Elected by the shareholders, the Tassal Group's board of directors comprises two types of representatives: Tassal Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tassal. The board's role is to monitor Tassal Group's management team and ensure that shareholders' interests are well served. Tassal Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tassal Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthew Vince, Head Marketing | ||
| BA LLB, Company Sec | ||
| Heidi Smith, Sr Communities | ||
| Hamish Sutton, Head Chain | ||
| BCom BCom, CEO MD | ||
| Kaylene Little, Head of Human Resources, QA and OH&S | ||
| Andrew Creswell, CFO and Group Financial Controller | ||
| Mark Asman, Head Aquaculture |
Tassal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Tassal Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0674 | |||
| Return On Asset | 0.0452 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 1.1 B | |||
| Shares Outstanding | 215.7 M | |||
| Shares Owned By Insiders | 19.79 % | |||
| Shares Owned By Institutions | 26.27 % | |||
| Price To Earning | 15.80 X | |||
| Price To Book | 1.26 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Tassal Pink Sheet
If you are still planning to invest in Tassal Group Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tassal Group's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |